Based on the results of the first half of 2017, medicinal products deliveries were made under the High-cost diseases (HCD) program for the amount of almost 25 billion rubles. This is more than a half of the amount budgeted for this item of expenditure for the year. It is assumed that by the end of 2017, the costs of procurement for HCD will exceed 2016’s costs, and will reach the level of previous years (Fig. 1).
Based on the results of the first half of 2017, medicinal products deliveries were made under the High-cost diseases (HCD) program for the amount of almost 25 billion rubles. This is more than a half of the amount budgeted for this item of expenditure for the year. It is assumed that by the end of 2017, the costs of procurement for HCD will exceed 2016’s costs, and will reach the level of previous years (Fig. 1).
The reproduction of materials is allowed only if the limitations established by the Rightholder are observed, with mention of the author of the materials used and the reference to ALPHARM LLC as a source, with a mandatory hyperlink to www.alpharm.ru website.